Biotech - Technical Analysis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech - Technical Analysis

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (398)	6/6/2002 6:04:15 PM
From: Jibacoa	Read Replies (1) of 544

AVXT Also did fairly well today on low volume. Apparently is reacting to the FDA granting it "Orphan Drug" Designation (which it already had in Europe since last year.<g>)fot its SCID-Xl technology that is currently in development in France. The drug is for treatment of Combined Immundeficiency Syndrome (SCID)albeit the incidence of the disease is rather low.<g> siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next